BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 37179402)

  • 1. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
    Zhao LY; Mei JX; Yu G; Lei L; Zhang WH; Liu K; Chen XL; Kołat D; Yang K; Hu JK
    Signal Transduct Target Ther; 2023 May; 8(1):201. PubMed ID: 37179402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.
    Chrysostomou D; Roberts LA; Marchesi JR; Kinross JM
    Gastroenterology; 2023 Feb; 164(2):198-213. PubMed ID: 36309208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies.
    Chen Y; Wang X; Ye Y; Ren Q
    Med Oncol; 2023 Dec; 41(1):25. PubMed ID: 38129370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
    Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the microbiome in drug resistance in gastrointestinal cancers.
    Garajová I; Balsano R; Wang H; Leonardi F; Giovannetti E; Deng D; Peters GJ
    Expert Rev Anticancer Ther; 2021 Feb; 21(2):165-176. PubMed ID: 33115280
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging roles of the gut microbiota in cancer immunotherapy.
    Shi Z; Li H; Song W; Zhou Z; Li Z; Zhang M
    Front Immunol; 2023; 14():1139821. PubMed ID: 36911704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic cell death: A link between gut microbiota and anticancer effects.
    Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
    Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
    Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
    Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
    J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of gut microbiota in cancer treatment: friend or foe?
    Cheng WY; Wu CY; Yu J
    Gut; 2020 Oct; 69(10):1867-1876. PubMed ID: 32759302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
    Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
    World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.
    Chattopadhyay I; Nandi D; Nag A
    Semin Cancer Biol; 2021 May; 70():98-111. PubMed ID: 32739479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota: a potential target for improved cancer therapy.
    Zhao M; Jiang G; Zhou H; Li J; Xiang W; Li S; Wang H; Zhou J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):541-552. PubMed ID: 36550389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.